文献速递产科妇科生殖医学

「阿舍曼综合征的威胁」:一项倾向性评分匹配的胎儿-母体结局研究

"The threat of Asherman syndrome": a propensity score-matched study of fetal-maternal outcomes.
PubMed 文献 · Fertil Steril · 2025-06-25

这项在三级转诊中心2011年1月至2022年12月开展的倾向性评分匹配队列研究,纳入428例阿舍曼综合征(AS)宫腔镜治疗后获得活产妊娠(>22周)的女性与2145例无AS史对照。AS组围产儿死亡、早产、臀位、产后出血及手取胎盘风险均显著升高,出生体重较低主要归因于早产,小于胎龄儿未见增加;亚组分析显示AS前有产后手术及重度粘连者风险最高。作者认为AS治疗后妊娠属高危,需专门产前保健并制定临床指南。

要点

  • AS宫腔镜治疗后妊娠的围产儿死亡风险升高(OR 3.8,95%CI 1.8-8.2)。
  • AS组早产(OR 3.14)、臀位(OR 3.57)、产后出血(OR 2.52)风险均升高。
  • AS组手取胎盘可能性约为对照的8.5倍(95%CI 6.2-11.7)。

核心结论

  • AS宫腔镜治疗后妊娠与胎儿-母体并发症风险统计学显著升高相关。
  • 作者认为这些发现凸显了对AS女性进行专门产前保健和风险管理的必要性。
  • 作者强调制定临床指南以优化该高危人群妊娠结局的重要性。

研究设计与样本

  • 倾向性评分匹配队列研究,在三级转诊中心于2011年1月至2022年12月开展。
  • 纳入428例接受AS治疗并随后获得活产妊娠(>22周)的女性,以及2145例无AS史的匹配对照组。
  • 暴露为AS宫腔镜粘连分离术及标准化术后管理,包括放置宫内节育器和激素治疗。
  • 倾向性评分匹配用于控制年龄、日历年、产次和孕次。

主要发现

  • AS队列发生12例围产儿死亡(OR 3.8;95%CI 1.8-8.2),主要与极度早产相关。
  • AS组早产风险升高(OR 3.14;95%CI 2.31-4.26),臀位风险升高(OR 3.57;95%CI 2.44-5.23),产后出血风险升高(OR 2.52;95%CI 1.95-3.25)。
  • 手取胎盘的可能性约为对照的8.5倍(OR 8.5;95%CI 6.2-11.7)。
  • AS组出生体重较低,但这主要归因于早产,未观察到小于胎龄儿发生率增加。
  • 亚组分析显示,AS前有产后手术者及重度粘连者风险最高。

临床怎么用

  • 作者认为AS治疗后妊娠女性需要专门的产前保健和风险管理。
  • 作者强调需要制定临床指南以优化该高危人群的妊娠结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study fetal-maternal outcomes in pregnancies after hysteroscopic treatment of Asherman syndrome (AS) compared with pregnancies without a history of AS. A secondary objective was to examine whether outcomes varied on the basis of AS characteristics. DESIGN: A propensity score-matched cohort study conducted at a tertiary referral center between January 2011 and December 2022. SUBJECTS: The study included 428 women treated for AS who subsequently achieved a viable pregnancy (>22 weeks of gestation) and 2,145 matched comparison group without a history of AS. EXPOSURE: Women underwent hysteroscopic adhesiolysis for AS, followed by standardized postoperative care, including intrauterine device placement and hormonal treatment. Propensity score matching was applied to control for age, calendar year, parity, and gravidity. MAIN OUTCOME MEASURES: The primary outcomes included perinatal death, preterm delivery, breech presentation, birth weight, manual removal of the placenta, and mode of delivery and postpartum hemorrhage. RESULTS: Women with a history of AS experienced statistically significantly higher risks of adverse fetal-maternal outcomes than the comparison group. Twelve perinatal deaths (odds ratio [OR], 3.8; 95% confidence interval [CI], 1.8-8.2) occurred in the AS cohort, primarily associated with extreme prematurity. Furthermore, outcomes included increased risks of preterm birth (OR, 3.14; 95% CI, 2.31-4.26), breech presentation (OR, 3.57; 95% CI, 2.44-5.23), and postpartum hemorrhage (OR, 2.52; 95% CI, 1.95-3.25). The likelihood of manual removal of the placenta was eightfold higher (OR, 8.5; 95% CI, 6.2-11.7). Although the birth weight was lower in the AS group, this was largely due to prematurity, with no observed increase in the rate of small for gestational age infants. Subgroup analyses revealed the highest risk in women with a postpartum procedure preceding AS and those with severe adhesions. CONCLUSION: Pregnancies after hysteroscopic treatment for AS are associated with statistically significantly increased risks of fetal-maternal complications. These findings highlight the need for specialized prenatal care and risk management for women with AS. This study underscores the importance of developing clinical guidelines to optimize pregnancy outcomes in this high-risk population.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Hanstede MMF, Veersema S, Emanuel MH, et al. "The threat of Asherman syndrome": a propensity score-matched study of fetal-maternal outcomes. Fertil Steril. 2025. PMID: 40578664. doi:10.1016/j.fertnstert.2025.06.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。